<VariationArchive RecordType="classified" VariationID="830820" VariationName="NC_000006.12:g.(?_162262525)_(162275409_?)dup" VariationType="Duplication" Accession="VCV000830820" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="819680" VariationID="830820">
      <GeneList>
        <Gene Symbol="PRKN" FullName="parkin RBR E3 ubiquitin protein ligase" GeneID="5071" HGNC_ID="HGNC:8607" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q26</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="161347417" stop="162727766" display_start="161347417" display_stop="162727766" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="161768589" stop="163148833" display_start="161768589" display_stop="163148833" Strand="-" />
          </Location>
          <OMIM>602544</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000006.12:g.(?_162262525)_(162275409_?)dup</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q26</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" innerStart="162683557" innerStop="162696441" display_start="162683557" display_stop="162696441" variantLength="12885" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.(?_162683557)_(162696441_?)dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.(?_162683557)_(162696441_?)dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000006.12:g.(?_162262525)_(162275409_?)dup AND Autosomal recessive juvenile Parkinson disease 2" Accession="RCV001031424" Version="1">
        <ClassifiedConditionList TraitSetID="1942">
          <ClassifiedCondition DB="MedGen" ID="C1868675">Autosomal recessive juvenile Parkinson disease 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-07-29" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10072423</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10824074</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22956510</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301651</ID>
          <ID Source="BookShelf">NBK1478</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1942" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3274" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease autosomal recessive, early onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Juvenile parkinsonism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease 2</ElementValue>
                <XRef ID="Parkinson+disease+2/9086" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinsonism, early onset, with diurnal fluctuation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive juvenile Parkinson disease 2</ElementValue>
                <XRef ID="MONDO:0010820" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Juvenile Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Early-Onset Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PDJ</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PARK2</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Parkin type of early-onset Parkinson disease (PARK-Parkin) is characterized by the cardinal signs of Parkinson disease (PD): bradykinesia, resting tremor, and rigidity. The median age at onset is 31 years (range: 3-81 years). The disease is slowly progressive: disease duration of more than 50 years has been reported. Clinical findings vary; hyperreflexia is common. Lower-limb dystonia may be a presenting sign and cognitive decline appears to be no more frequent than in the general population. Dyskinesia as a result of treatment with levodopa frequently occurs.</Attribute>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9642" />
                <XRef ID="9642" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301402</ID>
                <ID Source="BookShelf">NBK1223</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301651</ID>
                <ID Source="BookShelf">NBK1478</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="EFNS/MDS-ES, 2013">
                <ID Source="PubMed">23279440</ID>
              </Citation>
              <XRef ID="2828" DB="Orphanet" />
              <XRef ID="C1868675" DB="MedGen" />
              <XRef ID="MONDO:0010820" DB="MONDO" />
              <XRef Type="MIM" ID="600116" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2355984" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="3845734|MedGen:C1868675" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194730" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22956510</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10072423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10824074</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301651</ID>
          </Citation>
          <Comment>This variant results in a copy number gain of the genomic region encompassing exon 3 of the PRKN gene. While the exact position of this variant cannot be determined from this data, sub-genic copy number gains are generally in tandem (PMID: 25640679) and may result in an absent or disrupted protein product. This variant has been observed to be homozygous or in combination with another Pathogenic PRKN variant in individuals affected with clinical features of PRKN-related early-onset Parkinson's disease (PMID: 10824074, Invitae). Loss-of-function variants in PRKN are known to be pathogenic (PMID: 10072423, 20301651, 22956510). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PARK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.(?_162683557)_(162696441_?)dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Parkinson disease 2</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1868675" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2355984" TraitType="Disease" MappingType="Name" MappingValue="Parkinson disease 2" MappingRef="Preferred">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

